Study Protocol of a Multicenter, Randomized, Single-Blind Trial: Efficacy and Safety of Remimazolam Tosylate for Sedation in ICU Patients.
Ning LiuZhiyi JiangYao NieLingyun ZuoChuanxi ChenXiang SiQin LiuMinying ChenXiangdong GuanPublished in: Advances in therapy (2023)
ClinicalTrials.gov identifier, NCT05152303.
Keyphrases
- study protocol
- double blind
- phase iii
- end stage renal disease
- open label
- clinical trial
- randomized controlled trial
- newly diagnosed
- ejection fraction
- phase ii
- chronic kidney disease
- placebo controlled
- mechanical ventilation
- intensive care unit
- prognostic factors
- cross sectional
- acute respiratory distress syndrome
- patient reported outcomes
- patient reported